Annika Goos‐Nilsson

Hepatic Glucocorticoid Receptor Antagonism Is Sufficient to Reduce Elevated Hepatic Glucose Output and Improve Glucose Control in Animal Models of Type 2 Diabetes

Peer B. Jacobson, Thomas W von Geldern, Lars Öhman et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 77 citations · Full text

Medicine, Endocrinology, Pharmacology +16

Liver-Selective Glucocorticoid Antagonists:  A Novel Treatment for Type 2 Diabetes

Thomas W von Geldern, Noah P. Tu, Philip R. Kym et al. · Journal of Medicinal Chemistry · 2004 · 71 citations · Full text

Medicine, Endocrinology, Pharmacology +17

3-(3-Aryloxyaryl)imidazo[1,2-a]pyridine sulfones as liver X receptor agonists

Robert R. Singhaus, Ronald C. Bernotas, Robert J. Steffan et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 60 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6

Discovery of Phenyl Acetic Acid Substituted Quinolines as Novel Liver X Receptor Agonists for the Treatment of Atherosclerosis

Baihua Hu, Michael D. Collini, Rayomand J. Unwalla et al. · Journal of Medicinal Chemistry · 2006 · 51 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Discovery and SAR of cinnolines/quinolines as liver X receptor (LXR) agonists with binding selectivity for LXRβ

Baihua Hu, Raymound Unwalla, Michael D. Collini et al. · Bioorganic & Medicinal Chemistry · 2009 · 51 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12